Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydrastis canadensis extract is an herbal extract derived from the root and rhizome of the Hydrastis canadensis (goldenseal) plant, native to eastern North America. It has a long history of use in traditional medicine, notably by Native American populations, to treat a range of ailments such as infections, digestive issues, skin and eye irritations, and mucosal inflammation. The extract contains isoquinoline alkaloids, mainly berberine, hydrastine, and canadine, which are believed responsible for its purported antibacterial, antifungal, anti-inflammatory, and immunomodulatory effects. Modern uses include adjunctive therapy for upper respiratory tract infections, digestive disturbances, and topical applications for minor wounds and mucosal irritations. Despite widespread use, high-quality clinical evidence supporting these uses is limited, and most supporting data are in vitro or animal studies. Hydrastis canadensis extract is primarily available as dietary supplements in forms such as teas, capsules, tinctures, drops, and topical formulations[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydrastis canadensis extract.